Response to Rivastigmine Transdermal Patch or Memantine plus Rivastigmine Patch is affected by Apolipoprotein E Genotype in Alzheimer Patients-Reference-Cited by-同舟云学术

Response to Rivastigmine Transdermal Patch or Memantine plus Rivastigmine Patch is affected by Apolipoprotein E Genotype in Alzheimer Patients

Published:2012 Issue:3-4 Volume:34 Page:167-173
ISSN:1421-9824
Container-title:Dementia and Geriatric Cognitive Disorders
language:en
Short-container-title:Dement Geriatr Cogn Disord

Author:

Han Hyun Jeong,Kim Byeong C.,Lee Jun-Young,Ryu Seung-Ho,Na Hae Ri,Yoon Soo Jin,Park Hyun Young,Shin Joon Hyun,Cho Soo-Jin,Yi Hyon-Ah,Choi Mun Seong,Heo Jae-Hyeok,Park Kyung Won,Kim Kwang K.,Choi Seong Hye

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Cognitive Neuroscience,Geriatrics and Gerontology

Reference37 articles.

1. Alzheimer's Disease

2. Risk Estimates of Dementia by Apolipoprotein E Genotypes From a Population-Based Incidence Study: The Rotterdam Study

3. Apolipoprotein E Genotype in Sporadic Early- and Late-Onset Alzheimer’s Disease

4. Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease

5. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomaterials Comprising Implantable and Dermal Drug Delivery Targeting Brain in Management of Alzheimer’s Disease: A Review;Regenerative Engineering and Translational Medicine;2024-03-04

2. Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms;Genes;2023-11-06

3. Alzheimer's disease phenotype based upon the carrier status of the apolipoprotein E ɛ4 allele;Brain Pathology;2023-08-30

4. Role of Pharmacogenomics in Individualizing Treatment for Alzheimer’s Disease;CNS Drugs;2022-03-30

5. Genistein and Galantamine Combinations Decrease β-Amyloid Peptide (1–42)–Induced Genotoxicity and Cell Death in SH-SY5Y Cell Line: an In Vitro and In Silico Approach for Mimic of Alzheimer’s Disease;Neurotoxicity Research;2020-07-01